How Pantheon Clinical Research Uses Inato to Accelerate Patient Pre-Screening
Inato empowers site staff to make quick, informed decisions about patient eligibility
For Sponsors
Gain an advantage with accelerated results and expanded access to underrepresented patients.
For Sites
Succeed by self-selecting best-fit trials and leveraging AI-enhanced tools.
Learn how we're bringing together senior leaders from top pharma companies and community research sites to drive significant advancements across the clinical research ecosystem
The Latest from Inato
Inato empowers site staff to make quick, informed decisions about patient eligibility
Early users reported time-savings of up to 90%, at a 95% accuracy rate.
Early users reported that Inato reduced their pre-screening times by more than 50%, and up to 90%